NEW YORK, Oct. 06, 2017 -- The Alzheimer’s Foundation of America (AFA) applauded the issuance of a new federal postage stamp to help raise awareness and funds for the 5 million Americans currently living with Alzheimer’s disease. AFA has long advocated for the issuance of the stamp as a way to raise Alzheimer’s awareness and support research efforts to find a cure for the disease, which is currently the sixth leading cause of death in America.
“AFA has been calling for this step for years, and it’s wonderful to see the Postal Service take action to benefit the millions of Americans affected by Alzheimer’s,” said Charles J. Fuschillo, Jr., AFA’s President & CEO. “Not only will this new stamp help raise awareness about Alzheimer’s, it will invest additional, desperately needed research funding that will help bring us one step closer to a cure for this terrible disease. We thank the United States Postal Service, as well as Representatives Maxine Waters and Elijah Cummings who worked to make this stamp a reality.”
The United States Postal Service (USPS) announced its intention to issue the new Alzheimer’s semipostal stamp in November, which is Alzheimer’s Awareness Month, and sell it for a period of two years.
Semipostal stamps, currently sold for 60-cents, are first-class mail postage stamps that are issued and sold by USPS above the regular first-class stamp rate to raise funds for designated causes. The net difference between the two rates is contributed to the specific cause. According to the USPS, funds raised through the Alzheimer’s semipostal stamp will be distributed to the US Department of Health and Human Services.
The Alzheimer’s stamp is the first of five different semipostal stamps USPS will be issuing over the next 10 years.
About Alzheimer’s Foundation of America (AFA):
The Alzheimer’s Foundation of America, based in New York, is a non-profit organization that unites more than 2,500 member organizations nationwide in the goal of providing optimal care and services to individuals confronting dementia, and to their caregivers and families. Its services include a national, toll-free helpline (866-232-8484) staffed by licensed social workers, educational materials, a free quarterly magazine for caregivers and “AFA Partners in Care” dementia care training for healthcare professionals. For more information about AFA, call 866-232-8484, visit www.alzfdn.org, follow us on Twitter, or connect with us on Facebook or LinkedIn.
CONTACTS: Chris Schneider 866-232-8484 x121 [email protected]


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



